Method for repairing hba2 gene mutations by single base editing and use thereof
AssigneeGuangzhou Reforgene Medicine Co., Ltd.
InventorsJunbin Liang, Hui Xu, Lu Ye, Simiao Lin
Life of this patent
Estimating the term…
Loading patent…
AssigneeGuangzhou Reforgene Medicine Co., Ltd.
InventorsJunbin Liang, Hui Xu, Lu Ye, Simiao Lin
Estimating the term…
A method for repairing HBA2 gene mutations by single base editing and use thereof, belonging to the technical field of gene editing. The method comprises following steps: contacting a single base editor and gRNA with an HBA gene sequence to be edited and repaired, deaminating the codon target cytosine base at CD142 in the HBA gene sequence, and converting the cytosine into thymine. According to the method, pathogenic mutation sites can be accurately edited without generating double-strand breaks and affecting chromatin conformation and genome stability, without generating random insertions of large-fragment genes into genomes, which have a low influence on cancer gene activation or tumor-inhibiting gene inactivation, and without generating random insertions/deletions at other sites of a genome. The expression of the repaired target gene is regulated by all regulatory elements of natural HBA2; therefore, the method is very safe and can also better balance the expression of α/β globin.
A method for repairing an HBA2 gene mutation by single base editing, comprising the following steps:
(canceled)
A composition for repairing an HBA2 gene mutation, comprising a single base editor and a gRNA, wherein
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.